Abstract
There is a paucity of epidemiological data on the risk of comorbidities in adults with persistent or chronic immune thrombocytopenia (ITP). In this study, we compared the rates of cataracts, diabetes, renal failure, vascular events, lymphoma, and leukemia among patients with and without persistent or chronic ITP. Using administrative data, adult patients with medical claims for ITP from January, 2000 through September, 2006 were identified. An age- and gender-matched comparison cohort without evidence of ITP was randomly selected. The incidence rate ratio (IRR) of each comorbidity among ITP patients relative to the comparison group was estimated using Poisson regression, adjusting for baseline covariates. A total of 3,131 patients with persistent or chronic ITP were identified, and 9,392 were selected for the comparison cohort. The adjusted IRRs were as follows: diabetes 1.73 (95% CI 1.36–2.20), renal failure 2.05 (95% CI 1.67–2.51), any vascular event 1.70 (95% CI 1.41–2.05), lymphoma 5.91 (95% CI 2.61–13.37), leukemia 19.83 (95% CI 5.84–67.34), and mortality 4.21 (95% CI 3.06–5.79). There was no increased risk for cataract or myocardial infarction in the ITP cohort. Patients with persistent or chronic ITP are at increased risk for several comorbidities including hematologic malignancies, relative to a matched comparison cohort.
Similar content being viewed by others
References
Rodeghiero F, Stasi R, Gernsheimer T, Michel M, Provan D, Arnold DM, et al. Standardization of terminology, definitions and outcome criteria in immune thrombocytopenic purpura of adults and children: report from an international working group. Blood. 2009;113:2386–93.
Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med. 2002;346:995–1008.
Satia J, Acquavella J, Hollowell J, Rutstein M. Descriptive epidemiology of immune thrombocytopenic purpura in three European countries. Haematologica. 2006;91(s1):0936 (Abstract Book).
Segal JB, Powe NR. Prevalence of immune thrombocytopenia: analyses of administrative data. J Thromb Haemost. 2006;4:2377–83.
Deitz AC, Laurent SA, Kobayashi MG,Hall SA, Feudjo-Tepie MA. Prevalence estimate of idiopathic thrombocytopenic purpura (ITP) in the United States. Blood. 2006;108:3955 (Abstract Book).
Feudjo-Tepie MA, Robinson NJ, Bennett D. Prevalence of diagnosed chronic immune thrombocytopenic purpura in the US: analysis of a large US claim database: a rebuttal. J Thromb Haemost. 2008;6:711–2.
Landgren O, Engels EA, Pfeiffer RM, Gridley G, Mellemkjaer L, Olsen JH, et al. Autoimmunity and susceptibility to Hodgkin lymphoma: a population-based case-control study in Scandinavia. J Natl Cancer Inst. 2006;98:1321–30.
Feudjo-Tepie MA, Roux GL, Beach KJ, Bennett D, Robinson NJ. Comorbidities of idiopathic thrombocytopenic purpura: a population-based study. Adv Hematol. 2009;2009:963506, 12 pages. doi:10.1155/2009/963506.
Feudjo-Tepie MA, Hall SA, Logie J, Robinson NJ. Risk of cataract among idiopathic thrombocytopenic purpura patients in the UK general practice research database. Pharmacoepidemiol Drug Saf. 2009;18:380–5.
Segal JB, Powe NR. Accuracy of identification of patients with immune thrombocytopenic purpura through administrative records: a data validation study. Am J Hematol. 2004;75:12–7.
ISPE. Guidelines for good pharmacoepidemiology practices (GPP). Pharmacoepidemiol Drug Saf. 2008;17:200–8.
Acknowledgments
We thank Dr. Sumitra Shantakumar for helping to design the study and develop the protocol, and Ms. Claire Chiang MS for data analysis.
Conflict of interest
The authors declare no conflict of interest in the preparation of this work.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Enger, C., Bennett, D., Forssen, U. et al. Comorbidities in patients with persistent or chronic immune thrombocytopenia. Int J Hematol 92, 289–295 (2010). https://doi.org/10.1007/s12185-010-0636-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12185-010-0636-3